Navigation Links
Process found to play role in rheumatoid arthritis could lead to new treatment
Date:1/29/2009

Although the origin of rheumatoid arthritis (RA) remains unclear, bioactive proteins known as cytokines, particularly TNFα and IL-6, which are involved in inflammation, play a major role in the disease by contributing to joint and tissue destruction. Placenta growth factor (PIGF), another cytokine, has been thought to be critical for a new blood vessel formation in the placenta to sufficiently deliver oxygen and nutrients to fetus. A new study examined the effects of PIGF on the inflammatory process of RA. The results suggest that PIGF may play an important role in inflammation in RA joints. The study was published in the February issue of Arthritis & Rheumatism (http://www3.interscience.wiley.com/journal/76509746/home).

Led by Wan-Uk Kim of Catholic University of Korea inSeoul, Korea, researchers analyzed blood and synovial fluid cells from RA patients and healthy controls and found that synovial cells were the major source of PIGF production in RA patients and that PIGF stimulates TNFα and IL-6 production. They also found that the PlGF-induced increases in TNFα and IL-6 production may be caused by high levels of flt-1, a PlGF receptor, which are linked to the inflammatory response of RA patients. In addition, the researchers identified a novel peptide to inhibit PlGF action. When injected into arthritic mice, this peptide reduced the severity of arthritis and prevented its progression. They also found that elimination of PIGF gene in mice prevented the development of antibody-induced arthritis.

The peptide they identified inhibits binding of PIGF to its receptor flt-1and could be valuable from a clinical standpoint, since it is easily synthesized and does not elicit unwanted immune response.

"These findings provide new insight into the pathogenic mechanism of RA and emphasize the importance of PIGF and flt-1 as potential candidates for th
'/>"/>

Contact: Sean Wagner
medicalnews@bos.blackwellpublishing.com
781-388-8550
Wiley-Blackwell
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Brain imaging reveals breakdown of normal emotional processing
2. NYU study points to lasting impact of mild hearing loss on neurological processes
3. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
4. MedImmune Resolves FDA Observations Regarding Manufacturing Process for FluMist(R)
5. Delhaize Group Selects Trintechs AssureNET GL to Improve Compliance Process Efficiency
6. Labopharm provides update on U.S. regulatory process for once-daily Tramadol
7. BioProcessors Launches SimCell(TM) Services to Meet Increased Customer Demand
8. Orthofix International Acquires InSWing(TM) Interspinous Process Spacer
9. Cruel Deaths in Mexico a Result of Closing U.S. Horse Processing Plants: AVMA
10. Green Pet Products Introduces a New, Innovative Process to the Small Animal and Bird Litter/Bedding Category
11. ThermoGenesis Announces 510(k) Clearance for AutoXpress(TM) Cord Blood Processing System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2015)... ... August 30, 2015 , ... InHealth Media ( http://www.inhealthmedia.com ... Global Communications Director for InHealth Media. Mr. Spector comes with a wide ... years doing on-air television, producing shows, on air-radio and media relations. , ...
(Date:8/30/2015)... ... August 30, 2015 , ... ... medical devices for the treatment of prostate cancer, has announced the roll-out of ... at the treatment center in Puerto Vallarta, Mexico. , The Sonablate® technology currently ...
(Date:8/29/2015)... ... August 29, 2015 , ... "I have ... Miller Place, N.Y. "I specialize in manual therapy, and my invention will provide ... be used for additional muscle dysfunction throughout the body." , They developed THE ...
(Date:8/29/2015)... ... 2015 , ... Next weekend is Labor Day weekend, the last bash of ... 22nd this year). For IT security personnel, it should also mark the perfect time ... more costly than a simple headache. , Joe Caruso, founder and CEO-CTO of ...
(Date:8/29/2015)... ... 29, 2015 , ... Vascular Health Sciences announced today that ... Arterosil HP, and that all claims and counterclaims have been irrevocably dismissed. , ... in the United States District Court for the Southern District of Texas for ...
Breaking Medicine News(10 mins):Health News:InHealth Media Appoints New Global Communications Director 2Health News:Image Fusion Technology Combines MRI and Ultrasound Images to Treat Prostate Cancer 2Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 3Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 4
... ,Genzyme Corporation (Nasdaq: GENZ ) and Bioenvision, ... Bioenvision stockholders have voted to,approve the acquisition of ... meeting in New York. The transaction will be ... the company will,be delisted from Nasdaq. Fifty-six ...
... Vanda Pharmaceuticals,Inc. (Nasdaq: VNDA ) announced today ... of iloperidone at the 57th American Society of ... San Diego, CA, from October 23,through October 27, ... filing for iloperidone on September 27, 2007. Iloperidone ...
... evacuees to register on Safe and Well Website, ... California, forcing thousands to evacuate the area. During this,ongoing ... may feel confused,and anxious about the safety of their ... all those who have evacuated or who expect to,evacuate ...
... A team of Johns Hopkins scientists reports in this weeks ... that humans can be protected against the damaging effects of ... our environment by topical application of an extract of ... by parallel evidence obtained in mice, show that the degree ...
... 22 Shire plc (LSE: SHP,Nasdaq: SHPGY, TSX: ... (ADHD), announced today that it will present key,scientific ... scientific and,educational meeting of child and adolescent psychiatrists ... Shire studies to be presented are indicative of ...
... 22 HealthShares(TM) Inc., an investment,company with a series ... informed by Standard & Poor,s, the calculating agent for ... on,Thursday October 25, 2007, Amag Pharmaceuticals (Nasdaq: AMAG ... the HealthShares(TM) Diagnostics Index, and,Hologic Inc. (Nasdaq: HOLX ...
Cached Medicine News:Health News:Bioenvision Shareholders Approve Acquisition by Genzyme Corporation 2Health News:Bioenvision Shareholders Approve Acquisition by Genzyme Corporation 3Health News:Bioenvision Shareholders Approve Acquisition by Genzyme Corporation 4Health News:Vanda Pharmaceuticals to Present New Data on Iloperidone at the 2007 American Society of Human Genetics Annual Meeting 2Health News:Vanda Pharmaceuticals to Present New Data on Iloperidone at the 2007 American Society of Human Genetics Annual Meeting 3Health News:Southern California Wildfires Continue to Threaten Residential Areas 2Health News:Southern California Wildfires Continue to Threaten Residential Areas 3Health News:Broccoli sprout-derived extract protects against ultraviolet radiation 2Health News:Shire to Present New Scientific Data on its ADHD Treatments at a Major Psychiatric Meeting 2Health News:Shire to Present New Scientific Data on its ADHD Treatments at a Major Psychiatric Meeting 3Health News:Shire to Present New Scientific Data on its ADHD Treatments at a Major Psychiatric Meeting 4Health News:Shire to Present New Scientific Data on its ADHD Treatments at a Major Psychiatric Meeting 5Health News:HealthShares(TM) Announces Changes to the HealthShares(TM) Diagnostics and Composite Indexes 2Health News:HealthShares(TM) Announces Changes to the HealthShares(TM) Diagnostics and Composite Indexes 3
(Date:8/28/2015)... 2015 Research and Markets ... "Investigation Report on China,s Ranibizumab Market, 2012-2019" ... ranibizumab was approved by CFDA to treat wet age- ... a product of Novartis, is available in the Chinese ... developed drug for the treatment of wet AMD in ...
(Date:8/28/2015)... Aug. 28, 2015 Perrigo Company plc ("Perrigo") ... Mylan N.V. ("Mylan") (NASDAQ: MYL ) shareholder vote ... "Our views of Mylan,s offer to Perrigo shareholders ... on our Board,s careful reflection of the value available ... limited choices that Mylan has allowed its shareholders to ...
(Date:8/28/2015)... HERTFORDSHIRE, England and PITTSBURGH ... (NASDAQ: MYL ) today announced that its ... Company plc (NYSE: PRGO ; TASE) and ... Perrigo,s shareholders at an extraordinary general meeting of ... of two-thirds of the votes cast at the extraordinary general ...
Breaking Medicine Technology:Investigation Report on China's Ranibizumab Market, 2012-2019 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 4Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 5Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 2Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 3Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 4Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 5Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 6Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 7Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 8Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 9
... ADDISON, Texas and SALT LAKE CITY, Feb. 28, 2011 ... HUM ), is transforming the future of occupational ... improvements, creating exceptional and engaging experiences for clients and ... Concentra has joined the ranks of top U.S. consumer ...
... 28, 2011 ViroPharma Incorporated (Nasdaq: VPHM ) ... of ViroPharma, will present at the Citi 2011 Global Healthcare ...  The conference is being held at the Hilton New York ... president and chief financial officer, of ViroPharma, will present at ...
Cached Medicine Technology:Concentra is Writing a New Prescription on Health Care With Outstanding Service 2Concentra is Writing a New Prescription on Health Care With Outstanding Service 3Concentra is Writing a New Prescription on Health Care With Outstanding Service 4Concentra is Writing a New Prescription on Health Care With Outstanding Service 5ViroPharma to Participate in Two March Healthcare Conferences 2
The Doro Halo retractor system is designed for all neurosurgical applications where retraction of the brain tissue and an armrest is required....
Molt 9, excellent for subperiosteal tunneling....
Love-Adson periosteal elevator, semi sharp, blade width 3/16" (5 mm), length 6 1/2" (165 mm)....
Iowa University periosteal elevator, blade width 11/16" (17 mm), length 7 1/4" (184 mm)....
Medicine Products: